Prostvac - vaccinia-PSA-TRICOM vaccine; vPSA-TRI; Vaccinia-PSA-TRICOM/Fowlpox-PSA-TRICOM; vaccinia virus vector expressing prostate-specific antigen (PSA) and TRICOM, consisting of three co-stimulatory molecule transgenes B7.1, ICAM-1, and LFA-3, with co-administration of plus granulocyte-macrophage colony-stimulating factor (GM-CSF), followed by fowlpox virus vector expressing prostate-specific antigen (PSA) and TRICOM, recombinant -- Product Record

Prostate Cancer Vaccine, Poxvirus Vectors (rDNA)

    Nomenclature:
      Prostate Cancer Vaccine, Poxvirus Vectors (rDNA) [BIO]
      Prostvac [TR]
      fowlpox virus-PSA-TRICOM vaccine [SY]
      prostate-specific antigen (PSA) vaccine [SY]
      vaccinia virus vector expressing prostate-specific antigen (PSA) and TRICOM, consisting of three co-stimulatory molecule transgenes B7.1, ICAM-1, and LFA-3, with co-administration of plus granulocyte-macrophage colony-stimulating factor (GM-CSF), followed by fowlpox virus vector expressing prostate-specific antigen (PSA) and TRICOM, recombinant [SY]
      vaccinia-PSA-TRICOM vaccine [SY]
      vPSA-TRI [SY]

    FDA Class:  Biologic BLA

    Year of approval (FDA) = Biol

Index Terms: